Surgical Science Sweden AB (SUS) — Cash Flow Quality Index
Surgical Science Sweden AB (SUS) has a Cash Flow Quality Index of 3.51x as of March 2026. Operating cash flow of Skr65.31 Million exceeds net income of Skr18.63 Million, indicating high earnings quality where cash backs reported profits. Explore Surgical Science Sweden AB cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Surgical Science Sweden AB Cash Flow Quality Index (2015–2025)
Historical Cash Flow Quality Index for Surgical Science Sweden AB across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see SUS cash flow metrics.
Annual Cash Flow Quality Index for Surgical Science Sweden AB (2015–2025)
Year-by-year earnings quality comparison for Surgical Science Sweden AB.
| Year | Quality Index | Operating CF (SEK) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.19x | Skr79.80 Million | Skr66.82 Million | ▲ +14.6% |
| 2024 | 1.04x | Skr137.22 Million | Skr131.65 Million | ▲ +2.3% |
| 2023 | 1.02x | Skr238.29 Million | Skr233.97 Million | ▲ +27.8% |
| 2022 | 0.80x | Skr129.49 Million | Skr162.54 Million | ▲ +15.2% |
| 2021 | 0.69x | Skr39.08 Million | Skr56.52 Million | ▼ -40.5% |
| 2020 | 1.16x | Skr23.23 Million | Skr19.97 Million | ▼ -68.0% |
| 2019 | 3.64x | Skr55.20 Million | Skr15.18 Million | ▼ -12.7% |
| 2015 | 4.17x | Skr7.50 Million | Skr1.80 Million | — |